Zhenghong Peng

1.4k total citations
38 papers, 1.0k citations indexed

About

Zhenghong Peng is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Zhenghong Peng has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Hematology and 9 papers in Organic Chemistry. Recurrent topics in Zhenghong Peng's work include Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Click Chemistry and Applications (5 papers). Zhenghong Peng is often cited by papers focused on Chronic Myeloid Leukemia Treatments (10 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Click Chemistry and Applications (5 papers). Zhenghong Peng collaborates with scholars based in United States, China and Israel. Zhenghong Peng's co-authors include William G. Bornmann, Duoli Sun, Moshe Talpaz, Ji Yuan Wu, Nicholas J. Donato, Feng Meng, David S. Maxwell, Ashutosh Pal, Juri G. Gelovani and Ling Yuan Kong and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zhenghong Peng

38 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenghong Peng United States 15 526 265 238 185 136 38 1.0k
John K. Leighton United States 18 670 1.3× 424 1.6× 463 1.9× 270 1.5× 150 1.1× 34 1.6k
Haleh Saber United States 13 624 1.2× 276 1.0× 606 2.5× 243 1.3× 150 1.1× 20 1.6k
Zi-Jie Long China 23 797 1.5× 225 0.8× 387 1.6× 100 0.5× 239 1.8× 29 1.4k
Eric B. Springman United States 15 479 0.9× 234 0.9× 348 1.5× 142 0.8× 434 3.2× 25 1.1k
Karen Dunn United Kingdom 13 801 1.5× 510 1.9× 180 0.8× 261 1.4× 275 2.0× 29 1.4k
Anne Blackwood‐Chirchir United States 12 241 0.5× 414 1.6× 475 2.0× 366 2.0× 108 0.8× 22 1.0k
Michelle L. Kraus United States 7 466 0.9× 145 0.5× 447 1.9× 68 0.4× 129 0.9× 9 1.1k
Ramesh Jayaraman Singapore 15 433 0.8× 253 1.0× 352 1.5× 344 1.9× 29 0.2× 18 898
Kiyoshi Okamoto Japan 15 611 1.2× 204 0.8× 514 2.2× 161 0.9× 267 2.0× 55 1.7k
Franklin C. Harwood United States 16 919 1.7× 180 0.7× 547 2.3× 213 1.2× 144 1.1× 17 1.4k

Countries citing papers authored by Zhenghong Peng

Since Specialization
Citations

This map shows the geographic impact of Zhenghong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenghong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenghong Peng more than expected).

Fields of papers citing papers by Zhenghong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenghong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenghong Peng. The network helps show where Zhenghong Peng may publish in the future.

Co-authorship network of co-authors of Zhenghong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenghong Peng. A scholar is included among the top collaborators of Zhenghong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenghong Peng. Zhenghong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Qi, Mingqiang Gao, Lifeng Cheng, et al.. (2023). Genomic Scanning and Extracellular Proteomic Analysis of Dickeya dadantii DCE-01 Reveal Its Excellent Performance on Ramie Degumming. Fibers and Polymers. 24(4). 1517–1525. 1 indexed citations
3.
Zhang, Jingyue, et al.. (2022). Positive role and ethical problems of artificial intelligence in ophthalmology. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Liu, Lingbo, et al.. (2019). Maternal Health and Green Spaces in China: A Longitudinal Analysis of MMR Based on Spatial Panel Model. Healthcare. 7(4). 154–154. 8 indexed citations
5.
Leonard, Paul G., Nikunj Satani, David S. Maxwell, et al.. (2016). SF2312 is a natural phosphonate inhibitor of enolase. Nature Chemical Biology. 12(12). 1053–1058. 73 indexed citations
6.
Zuo, Mingxin, et al.. (2014). Abstract 5361: Development of targeted inhibitors against RecQ1 helicase. Cancer Research. 74(19_Supplement). 5361–5361. 1 indexed citations
7.
Peng, Zhenghong, David S. Maxwell, Duoli Sun, et al.. (2014). Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I). Bioorganic & Medicinal Chemistry. 22(4). 1450–1458. 12 indexed citations
8.
Arumugam, Thiruvengadam, Vijaya Ramachandran, Duoli Sun, et al.. (2013). Designing and Developing S100P Inhibitor 5-Methyl Cromolyn for Pancreatic Cancer Therapy. Molecular Cancer Therapeutics. 12(5). 654–662. 41 indexed citations
9.
Pal, Ashutosh, et al.. (2013). Asymmetric synthesis of the C1–C6 portion of the psymberin using an Evans chiral auxiliary. Tetrahedron Letters. 54(41). 5555–5557. 6 indexed citations
10.
Maxwell, David S., et al.. (2013). Synthesis of a macrocycle based on Linked Amino Acid Mimetics (LAAM). Tetrahedron Letters. 54(43). 5799–5801. 5 indexed citations
11.
Peng, Zhenghong, David S. Maxwell, Duoli Sun, et al.. (2013). Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level. Bioorganic & Medicinal Chemistry. 22(1). 623–632. 14 indexed citations
12.
Sun, Duoli, Zhenghong Peng, David S. Maxwell, et al.. (2013). Improved synthesis of 17β-hydroxy-16α-iodo-wortmannin, 17β-hydroxy-16α-iodoPX866, and the [131I] analogue as useful PET tracers for PI3-kinase. Bioorganic & Medicinal Chemistry. 21(17). 5182–5187. 4 indexed citations
13.
Angelo, Laura S., David S. Maxwell, Ji Yuan Wu, et al.. (2012). Binding partners for curcumin in human schwannoma cells: Biologic Implications. Bioorganic & Medicinal Chemistry. 21(4). 932–939. 18 indexed citations
14.
Peng, Zhenghong, Ashutosh Pal, Dongmei Han, et al.. (2011). Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma. Bioorganic & Medicinal Chemistry. 19(23). 7194–7204. 6 indexed citations
15.
16.
Schwartz, David A., Garth Powis, Yi He, et al.. (2009). The selective hypoxia inducible factor-1 inhibitor PX-478 providesin vivoradiosensitization through tumor stromal effects. Molecular Cancer Therapeutics. 8(4). 947–958. 75 indexed citations
17.
Fernández, Ariel, Ángela Sanguino, Zhenghong Peng, et al.. (2007). Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target. Cancer Research. 67(9). 4028–4033. 32 indexed citations
18.
Fernández, Ariel, Ángela Sanguino, Zhenghong Peng, et al.. (2007). An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. Journal of Clinical Investigation. 117(12). 4044–4054. 107 indexed citations
19.
Maxwell, David S., Ashutosh Pal, Zhenghong Peng, et al.. (2006). Structure-Based Drug Design of c-Kit Inhibitors for Use in the Treatment of Acute Myeloid Leukemia.. Blood. 108(11). 1906–1906. 1 indexed citations
20.
He, Pingsheng, Xiang‐Feng Zhou, Zhenghong Peng, & H. J. Geise. (1995). Aggregation behavior of benzoxazole cyanine dyes. Journal of Imaging Science and Technology. 39(3). 257–261. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John K. Leighton Breakdown of academic impact, for papers by Haleh Saber Breakdown of academic impact, for papers by Zi-Jie Long Breakdown of academic impact, for papers by Eric B. Springman Breakdown of academic impact, for papers by Karen Dunn Breakdown of academic impact, for papers by Anne Blackwood‐Chirchir Breakdown of academic impact, for papers by Michelle L. Kraus Breakdown of academic impact, for papers by Ramesh Jayaraman Breakdown of academic impact, for papers by Kiyoshi Okamoto Breakdown of academic impact, for papers by Franklin C. Harwood
Rankless by CCL
2026